Dental Practice Valuation Multiples in Arizona (2026)

Two Arizona general practices can collect the same $1.4 million, run the same five operatories, and sell for prices $1.2 million apart. Nothing about the dentistry explains the gap. The multiple is not a property of your practice. It's a property of your buyer, and of how legible your numbers are to whichever one you end up sitting across from.

Here's our call, stated plainly so you can disagree with it: most Arizona owners are reading a price list for a practice they don't own, and the ones restructuring the business to qualify for platform-level multiples are spending three to five years and real capital to reach a bid that will pay them less than the dentist across town would have paid this year. The EBITDA multiple headlines are real. They just aren't yours.

Arizona Has More Buyers Than Most States, and the Statute Is Why

Arizona is a permissive ownership state, and that single fact does more to set local pricing than anything happening in your hygiene column. Arizona Revised Statutes § 32-1201 defines a dental "business entity" as one whose ownership "includes any persons who are not licensed or certified to provide dental services." Translated: a non-dentist can own the practice outright. No corporate practice workaround, no management services agreement built to paper over a prohibition, no captive PC held by a friendly licensee in another state.

The compliance price for that is administrative rather than structural. Per a review of Arizona's ownership rules, non-dentist-owned entities must register with the Board for each office, renew every three years, and name a licensed Arizona dentist responsible for clinical services, with civil penalties up to $2,000 per violation for noncompliance. That is a rounding error against a seven-figure acquisition. Arizona had roughly 5,658 licensed dentists as of March 2025, and a buyer pool that includes anyone with capital.

So yes, Arizona practices attract institutional interest that a practice in a restrictive state would not see. The mistake is assuming interest and a bid are the same thing.

Three Buyers, Three Currencies, Three Prices

There are effectively three pricing regimes operating in this market at once, and they do not use the same denominator. Dental Transitions' 2026 multiple survey puts them at:

• Individual dentist buyers: 4.0x to 6.5x SDE, roughly 60% to 75% of trailing collections, for solo and two-doctor practices.
• Regional DSO add-ons: 5x to 8x adjusted EBITDA, for practices generating $1 million to $3 million of EBITDA.
• Private-equity-backed platforms: 9x to 11x adjusted EBITDA, on $3 million to $5 million EBITDA deals.

Read the second and third lines again, and read the EBITDA thresholds, not the multiples. A practice has to be throwing off $1 million of adjusted EBITDA, after paying market-rate doctor compensation to whoever does the dentistry, before the 5x to 8x band applies at all. That is not a $1.4 million practice. That is usually a group doing $4 million to $6 million of collections across multiple sites.

SDE and EBITDA are not two ways of saying the same thing. SDE includes your compensation as the producing owner. EBITDA removes it and replaces it with what it would cost to hire your replacement. For a solo practice where the owner produces most of the dentistry, that substitution is not a haircut. It's most of the number.

What Most Owners Get Wrong: Building Toward a Bid That Pays Less

The specific mistake, and we see it most often in owners aged 48 to 58 who have read three DSO articles and attended one transition seminar: adding operatories, a second location, or an associate specifically to reach "DSO scale," on the theory that a 9x multiple is strictly better than a 5x multiple.

It isn't better, because the multiples are applied to different bases. A 9x multiple on a number that has been reduced by a full associate's compensation can land below a 4x multiple on a number that hasn't. Owners who chase the bigger multiple without running both bases on their own books are optimizing the wrong half of the equation.

The second version of the same error: an owner adds a third and fourth operatory to grow collections, doesn't add the doctor hours or the patient flow to fill them, and ends up with more fixed overhead against flat production. In The Dental Signal Practice Market Index, built from 925 dental practices currently listed for sale nationally, the median listed practice has 5 operatories (middle half 4 to 7, n=754) and produces a median of $200,000 of collections per operatory (middle half $146,875 to $268,708, n=643). Those are asking-side figures, describing practices on the market rather than all practices. But the spread tells you something useful: the distance between the bottom and top of that range is use, not square footage. An owner at the 25th percentile of collections per operatory has a production problem that a fifth chair makes worse.

Running It on a $1.4 Million Practice in the East Valley

Take a single-location general practice collecting $1,400,000, five operatories, the owner producing about $900,000 of that with an associate covering the rest. Operating costs excluding owner compensation run 65% of collections, or $910,000. That leaves seller's discretionary earnings of $490,000.

On the individual-dentist basis, 4.0x SDE prices this at $1,960,000 and 6.5x prices it at $3,185,000. That $1,225,000 spread is the entire argument for spending money on clean financials, documented systems, and a real recall system before you list.

Now convert to the institutional basis. A buyer replacing the owner's $900,000 of production with an associate at 30% pays $270,000 in doctor compensation. Adjusted EBITDA becomes $220,000. Apply the top of the regional add-on band, 8x, and you get $1,760,000.

That is $200,000 less than the bottom of the dentist-buyer range. And it's a generous illustration, because this practice is $780,000 of EBITDA short of the $1 million floor where the 5x to 8x band actually applies. At $220,000 of EBITDA, a regional buyer is not bidding 8x. They're bidding what they need to bid to beat the dentist, and not a dollar more.

We wouldn't take the institutional deal on this practice, and we'd stop treating a DSO call as flattery. It's a market test, and you're the one being tested.

Your Own Pay Becomes a Line Item the Day You List

The add-back conversation is where most Arizona valuations get decided, and the one number owners consistently misjudge is their own compensation. Buyers do not care what you paid yourself. They care what it costs to buy your chair time at market.

The federal wage baseline gives you the floor. Per the Bureau of Labor Statistics May 2023 state estimates for Arizona, the state employed 2,140 general dentists at an annual mean wage of $231,890, and 230 dentists in all other specialties at $265,680. Those are employment wages, not owner earnings, and they undercount owner-operators who don't show up on anyone's payroll. But they are the number a lender's analyst reaches for when they want to know whether your claimed add-back is defensible.

Practically: if you paid yourself $150,000 last year to manage taxes, a buyer will not credit you with a $150,000 add-back and call it a day. They'll normalize to what an associate producing your volume would earn, and in a $1.4 million practice that is a larger figure than the BLS mean. If you paid yourself $600,000, the excess above market is a legitimate add-back, but only if you can document production by provider. Practices that can't split production by provider lose that argument, and the loss shows up as six figures of purchase price.

The same discipline applies to the rest of the add-back schedule. Your vehicle, your spouse's payroll, the family phone plan, the continuing education trip to Cabo. Every one of them is defensible in isolation and corrosive in aggregate, because a schedule with 22 line items reads as a seller who runs the practice as a personal account. Buyers discount the whole file, not just the questionable entries.

Demand Supports Prices. It Doesn't Rescue a Weak One.

The macro backdrop is genuinely good and is doing real work in these multiple ranges. The ADA Health Policy Institute reports national dental expenditures reached $189 billion in 2024, and that 45% of the U.S. population had a dental visit in 2022. Arizona's population growth compounds that locally.

But look at the second figure the way a buyer does. Fifty-five percent of the country did not see a dentist that year. That is a demand pool, not guaranteed revenue, and converting it takes marketing spend, schedule capacity, and a front desk that answers the phone. A buyer underwriting your practice is pricing your realized collections and your demonstrated new-patient flow, not the addressable market in your ZIP code. Practice Market Index listings show a median of $957,588 in collections across 753 practices with disclosed figures, and $946,000 across 644 general practices. Plenty of supply is on the shelf. Sellers who assume a rising market will carry a soft practice are the ones still listed 14 months later.

What Would Change Our Mind

Two things we're watching into 2027. First, whether regional add-on buyers start bidding SDE-comparable money at the $200,000 to $400,000 EBITDA level. If Arizona's permissive statute pulls enough capital into the state that add-on buyers compete for single-location practices collecting under $1.2 million, our advice flips, and small-practice owners should absolutely take those calls. Second, whether the 9x to 11x platform band holds if credit stays expensive. Platform multiples are a financing product as much as a dental one, and they compress faster than they expand.

What would move us fastest: a documented Arizona transaction where a group buyer paid above 4.0x SDE for a sub-$1 million EBITDA single site. We haven't seen one this year. Send us the closing statement if you have.

Three Things to Do Before You Take the Next Broker Call

Pull a production-by-provider report for the last 24 months this week, because without it you cannot defend a single dollar of owner-compensation add-back. Then calculate both numbers for your own practice: SDE as it sits, and EBITDA after subtracting what an associate at 30% would cost to replace your production. If the EBITDA figure lands under $1 million, price yourself on the dentist-buyer basis and stop reorganizing the business around a bid you won't receive. Trim the add-back schedule to the five entries you'd be comfortable defending line by line to a lender.

If you want to see both bases side by side before a broker frames them for you, our valuation calculator runs SDE and adjusted EBITDA off your own collections, overhead and owner compensation, and shows where your practice lands against the 2026 multiple ranges. It takes about six minutes with a P&L in front of you. Run your own numbers, then decide which buyer you're actually selling to.